198 related articles for article (PubMed ID: 15859538)
1. [Platelets and platelet microparticles glycoprotein IIb/IIIa complex in patients with unstable angina].
Dymicka-Piekarska V; Kemona H; Butkiewicz A; Bychowski J
Pol Merkur Lekarski; 2005 Jan; 18(103):9-12. PubMed ID: 15859538
[TBL] [Abstract][Full Text] [Related]
2. Elevated platelet-derived microparticle levels during unstable angina.
Singh N; Gemmell CH; Daly PA; Yeo EL
Can J Cardiol; 1995 Dec; 11(11):1015-21. PubMed ID: 8542543
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques.
Ikuta T; Naruko T; Ikura Y; Ohsawa M; Fukushima H; Shirai N; Itoh A; Haze K; Ehara S; Sasaki Y; Shibata T; Suehiro S; Ueda M
Int J Mol Med; 2005 Apr; 15(4):573-7. PubMed ID: 15754016
[TBL] [Abstract][Full Text] [Related]
4. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation after stenting with heparin-coated versus noncoated stents.
Gurbel PA; Bliden KP
Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.
Sill JC; Proper JA; Johnson ME; Uhl CB; Katusic ZS
Platelets; 2007 Dec; 18(8):613-9. PubMed ID: 18041653
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation status decreases after menopause.
Aldrighi JM; Oliveira RL; D'Amico E; Rocha T; Gebara OE; Rosano GM; Ramires JA
Gynecol Endocrinol; 2005 May; 20(5):249-57. PubMed ID: 16019369
[TBL] [Abstract][Full Text] [Related]
9. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
10. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
[TBL] [Abstract][Full Text] [Related]
11. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.
Collet JP; Montalescot G; Agnelli G; Van de Werf F; Gurfinkel EP; López-Sendón J; Laufenberg CV; Klutman M; Gowda N; Gulba D;
Eur Heart J; 2005 Nov; 26(21):2285-93. PubMed ID: 15932908
[TBL] [Abstract][Full Text] [Related]
12. [Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
Zhang M; Li X; Jiu G; Liu Y
Zhong Yao Cai; 2003 Oct; 26(10):738-40. PubMed ID: 14768394
[TBL] [Abstract][Full Text] [Related]
13. Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns.
Hoekstra JW; Roe MT; Peterson ED; Menon V; Mulgund J; Pollack CV; Miller C; Palabrica T; Harrington RA; Ohman EM; Gibler WB
Acad Emerg Med; 2005 May; 12(5):431-8. PubMed ID: 15863399
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb/IIIa inhibitors in unstable angina.
Theroux P
Curr Opin Cardiol; 1997 Sep; 12(5):447-52. PubMed ID: 9352171
[TBL] [Abstract][Full Text] [Related]
15. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).
Lim MJ; Eagle KA; Gore JM; Anderson FA; Dabbous OH; Mehta RH; Granger CB; Fox KA; Spencer FA; Goldberg RJ;
Am J Cardiol; 2005 Oct; 96(7):917-21. PubMed ID: 16188516
[TBL] [Abstract][Full Text] [Related]
16. [Expression patterns of platelet membrane glycoprotein in healthy adults].
Huang F; Liu R; Liu L
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
[TBL] [Abstract][Full Text] [Related]
17. [Increased platelet aggregation induced activity by anti-glycoprotein IIb/IIIa antibody in patients with acute coronary syndrome].
Voskoboĭ IV; Mazurov AV
Kardiologiia; 2004; 44(10):64-70. PubMed ID: 15477794
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
[TBL] [Abstract][Full Text] [Related]
19. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
20. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.
Dabbous OH; Anderson FA; Gore JM; Eagle KA; Fox KA; Mehta RH; Goldberg RJ; Agnelli G; Steg PG;
Heart; 2008 Feb; 94(2):159-65. PubMed ID: 17575335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
